Adaptive Biotechnologies (ADPT) Net Income Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) Net Income Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.44% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 67.24% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.22% |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | 2.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.79% |
| Dec 31, 2025 | 28.12% |
| Sep 30, 2025 | 29.97% |
| Jun 30, 2025 | -23.03% |
| Mar 31, 2025 | 47.66% |
| Dec 31, 2024 | 21.49% |
| Sep 30, 2024 | 51.08% |
| Jun 30, 2024 | 49.07% |
| Mar 31, 2024 | 48.81% |
| Dec 31, 2023 | -15.70% |
| Sep 30, 2023 | 56.48% |
| Jun 30, 2023 | 58.05% |
| Mar 31, 2023 | 45.72% |
| Dec 31, 2022 | 61.64% |
| Sep 30, 2022 | 52.40% |
| Jun 30, 2022 | 55.97% |
| Mar 31, 2022 | -124.73% |
| Dec 31, 2021 | 8.64% |
| Sep 30, 2021 | -220.96% |
| Jun 30, 2021 | -203.74% |